Rocket Pharmaceuticals, Inc. (RCKT)
2.18
-0.18
(-7.63%)
USD |
NASDAQ |
Oct 16, 16:00
2.21
+0.03
(+1.38%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash and Short Term Investments (Quarterly) : 283.75M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 283.75M |
| March 31, 2026 | 144.38M |
| December 31, 2025 | 188.93M |
| September 30, 2025 | 222.76M |
| June 30, 2025 | 271.49M |
| March 31, 2025 | 318.16M |
| December 31, 2024 | 372.34M |
| September 30, 2024 | 235.66M |
| June 30, 2024 | 278.82M |
| March 31, 2024 | 330.31M |
| December 31, 2023 | 373.18M |
| September 30, 2023 | 437.17M |
| June 30, 2023 | 307.04M |
| March 31, 2023 | 331.08M |
| December 31, 2022 | 356.39M |
| September 30, 2022 | 306.53M |
| June 30, 2022 | 321.37M |
| March 31, 2022 | 346.59M |
| December 31, 2021 | 388.74M |
| September 30, 2021 | 421.46M |
| June 30, 2021 | 426.83M |
| March 31, 2021 | 466.35M |
| December 31, 2020 | 482.72M |
| September 30, 2020 | 228.69M |
| June 30, 2020 | 249.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 275.90M |
| December 31, 2019 | 304.12M |
| September 30, 2019 | 240.56M |
| June 30, 2019 | 257.78M |
| March 31, 2019 | 196.59M |
| December 31, 2018 | 205.73M |
| September 30, 2018 | 127.48M |
| June 30, 2018 | 132.10M |
| March 31, 2018 | 182.70M |
| December 31, 2017 | 18.14M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 108.75M |
| March 31, 2017 | 114.70M |
| December 31, 2016 | 126.47M |
| September 30, 2016 | 137.58M |
| June 30, 2016 | 98.22M |
| March 31, 2016 | 102.26M |
| December 31, 2015 | 111.28M |
| September 30, 2015 | 118.36M |
| June 30, 2015 | 49.01M |
| March 31, 2015 | 53.14M |
| December 31, 2014 | 3.618M |
| September 30, 2014 | 5.357M |
| June 30, 2014 | |
| March 31, 2014 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 788.49M |
| Intellia Therapeutics, Inc. | 437.76M |
| Beam Therapeutics, Inc. | 1.153B |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |